Biopharmaceuticals : challenges and opportunities
著者
書誌事項
Biopharmaceuticals : challenges and opportunities
CRC Press, 2021
- : hbk
大学図書館所蔵 件 / 全2件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Biopharmaceuticals: Challenges and Opportunities
This book highlights how the traditional microbial process technology has been upgraded for the production of biologic drugs how manufacturing processes have evolved to meet the global market demand with quality products under the guidelines of internally recognized regulatory bodies.
It also carries information on how, armed with a deeper understanding of life-threatening diseases, biopharmaceutical companies and the life sciences industry have developed formal and informal partnerships with researchers in institutes, universities, and other R&D organizations to fulfil timely, quality production with perfect safety and security. One of the most interesting aspects of this book is the conceptual development of personalized medicine (or precision medicine) to provide the right treatment to the right patient, at the right dose at an earlier stage of development, for genetic diseases. Besides this, it also highlights the most challenging aspects of modern biopharmaceutical science, focusing on the hot topics such as design and development of biologic drugs; the use of diversified groups of host cells belonging to animals, plants, microbes, insects, and mammals; stem cell therapy and gene therapy; supply chain management of biopharmaceuticals; and the future scope of biopharmaceutical industry development.
This book is the latest resource for a wide circle of scientists, students, and researchers involved in understanding and implementing the knowledge of biopharmaceuticals to develop life-saving biologic drugs and to bring awareness to the development of personalized treatment that can potentially offer patients a faster diagnosis, fewer side effects, and better outcomes.
Features:
Explains how the traditional cell culture methodology has been changed to a fully continuous or partially continuous process
Explains how to design and fabricate living organs of body by 3D bioprinting technology
Focuses on how a biopharmaceutical company deals with various problems of regulatory bodies and develops innovative biologic drugs
Narrates in detail the updated information on stem cell therapy and gene therapy
Explains the development strategies and clinical significance of biosimilars and biobetters
Highlights the supply chain management of biopharmaceuticals
目次
Biopharmaceutical- A New Confront. Biopharmaceutical Production. Transitioning from Pharmaceutical to Biopharmaceutical. Biopharmaceutical from Animal cells. Plant Biomolecules and Therapeutic. Biosimilar. Biopharmaceutical Supply Chain Management.
「Nielsen BookData」 より